Seeing Is Believing
Healthcare - Sector
LGND is currently covered by 5 analysts with an average price target of $207.55. This is a potential upside of $17.58 (9.25%) from yesterday's end of day stock price of $189.97.
Ligand Pharmaceuticals's activity chart (see below) currently has 157 price targets and 108 ratings on display. The stock rating distribution of LGND is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 91.52% with an average time for these price targets to be met of 375.62 days.
Highest price target for LGND is $175, Lowest price target is $143, average price target is $156.25.
Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 01-Sep-2025. First documented stock forecast 11-Feb-2014.
Currently out of the existing stock ratings of LGND, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$175
$-11.98 (-6.41%)
$135
1 months 26 days ago
(01-Sep-2025)
10/10 (100%)
$11.27 (6.88%)
196
Buy
$160
$-26.98 (-14.43%)
$150
10 months 12 days ago
(15-Dec-2024)
15/15 (100%)
$37.66 (30.78%)
511
Buy
$157
10 months 17 days ago
(10-Dec-2024)
35/39 (89.74%)
$35.75 (29.48%)
620
Buy
$143
$-43.98 (-23.52%)
$140
10 months 17 days ago
(10-Dec-2024)
5/5 (100%)
$22.64 (18.81%)
305
Buy
$147
$-39.98 (-21.38%)
$135
11 months 20 days ago
(07-Nov-2024)
2/2 (100%)
$25.75 (21.24%)
280
What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?